LiqTech International, Inc. (NASDAQ: LIQT) ("LiqTech"), a clean technology company that manufactures and markets highly specialized filtration technologies, today announced that it has entered into a definitive securities purchase agreement with certain institutional investors (the "Private Placement").

LiqTech International, Inc. (NASDAQ: LIQT), a clean technology company that manufactures and markets highly specialized filtration products and systems, will report financial results for its fiscal year 2019 ended December 31, 2019 on Thursday, March 26, 2020 before the market opens. The Company has scheduled a conference call that same day, Thursday, March 26, 2020, at 9:00 a.m. ET, to review the results.

LiqTech International, Inc. (NASDAQ: LIQT) ("LiqTech"), a clean technology company that manufactures and markets highly specialized filtration technologies, today announced that it will be participating in the 32nd Annual ROTH Conference on Monday, March 16, 2020, at Ritz Carlton Hotel in Dana Point, California.

LiqTech International, Inc. (NASDAQ: LIQT) ("LiqTech"), a clean technology company that manufactures and markets highly specialized filtration technologies, is scheduled to participate in a virtual presentation and fireside chat at the May 2020 Lytham Partners Virtual Investor Conference on Wednesday, May 20, 2020 at 9:00am ET (6:00am PT).

Q4 2019 LiqTech International Inc Earnings Call

At Insider Monkey, we pore over the filings of nearly 750 top investment firms every quarter, a process we have now completed for the latest reporting period. The data we've gathered as a result gives us access to a wealth of collective knowledge based on these firms' portfolio holdings as of September 30. In this […]

NEW YORK, NY / ACCESSWIRE / March 26, 2020 / LiqTech International, Inc. (NASDAQ:LIQT) will be discussing their earnings results in their 2019 Fourth Quarter Earnings call to be held on March 26, 2020 ...

Q3 2019 LiqTech International Inc Earnings Call

Q2 2019 LiqTech International Inc Earnings Call

Everyone has to start somewhere. As is often repeated, today’s biggest companies came from humble beginnings, a garage being the initial home for mega corporations like Microsoft, Amazon and Disney.While it is common knowledge that the smaller the market cap, the larger the volatility, the opposite also rings true - the bigger a company becomes, the harder it gets to multiply its market cap, and therefore its share price. The trick, then, is to catch a promising stock before it explodes and to be able to reap the rewards its growth provides. But then follows the eternal question: how do we find one?TipRanks - a company that tracks and measures the performance of analysts - has a variety of tools at its disposal to find an undervalued stock. The site’s Analysts’ Top Stocks tool, which has filters such as market cap and sector, unearthed three such stocks. All three, coincidentally, currently have a Strong Buy consensus rating from the Street. Let’s get the lowdown.Dine Brands Global Inc (DIN)Despite a volatile 2019 for restaurant owner, Dine Brands, its share price is still up a very respectable 22% year-to-date. With a market cap of just $1.4 billion, the word on the Street is that the company is on its way to outstripping its small-cap status.Dine owns and franchises two restaurants, Applebee's Neighborhood Grill + Bar and International House of Pancakes (IHOP), which number in the thousands and are mostly based across the US.The company, though, has been expanding its international presence, and just this week announced the opening of its first IHOP restaurant in Lima, Peru. The new restaurant marks Dine’s 62nd restaurant in Latin America.The expansion follows October’s announcement of a deal with TravelCenters of America to open 94 IHOP restaurants at TA and Petro-branded interstate travel centers across the U.S. The agreement is IHOP’s largest in its history and significantly expands on the current 4 units at TravelCenters’ locationsRaymond James analyst Brian Vaccaro thinks the expansion bodes well, noting, “We believe IHOP remains an under-appreciated part of the Dine Brands story (even though it contributes approximately two-thirds of consolidated EBITDA) and that an acceleration in net new unit growth would benefit both EBITDA growth and broader investor sentiment towards the story.”To this end, Vaccaro reiterated an Outperform rating on DIN, alongside a price target of $95, indicating upside potential of 16%. (To watch Vaccaro’s track record, click here)Is the rest of the Street hungry for some Dine Brands? It appears so. A full house of 7 Buys bestows Strong Buy status on the restaurant owner. The average target price is $96.57, expressing the analysts’ confidence in an 18% increase over the next 12 months. (See Dine Brands stock analysis on TipRanks) Homology Medicines Inc (FIXX)With a market cap coming in at $966 million, this promising biotech has ample room for growth.Homology’s prime focus is on genetic medicines for patients with rare diseases. The company has several gene therapy and gene editing candidates in the pipeline. Recently, early efficacy and safety data from a clinical trial for HMI-102, its gene therapy for adults with PKU (phenylketonuria), exhibited promising signs. Further data is expected in mid-2020. The treatment is set to provide competition to BioMarin’s PKU gene therapy, BMN-307, which enters the clinic next year.Evercore’s Joshua Schimmer thinks “for now the FIXX horse is definitely in the race,” adding that “while the data is early, it is clearly encouraging.”“Fixx is developing a unique gene therapy and gene editing platform, with its proprietary AAVHSC vectors licensed from the City of Hope. The company will be initially targeting adult PKU patients using its gene therapy approach, with the aim of eventually advancing to pediatric patients with gene editing. Beyond PKU, excitement for the company stems from the potential to correct a wide range of genetic diseases with high precision,” the 5-star analyst said.Unsurprising, then, to find Schimmer reiterating an Outperform rating on FIXX, alongside a price target of $29. Should the target be met, investors stand to take home a nice 32% gain. (To watch Schimmer’s track record, click here)The Street is mostly in agreement with Schimmer on the early stage biotech. A Strong Buy consensus rating breaks down into 3 Buys and 1 Hold. An average price target of $32.50 indicates upside potential of 47%. (See Homology Medicines stock analysis on TipRanks) LiqTech International Inc (LIQT)The final ticker on our list has the smallest market cap of the lot. At $108 million, LiqTech qualifies rather as a ‘micro-cap’.Headquartered in Denmark, the clean technology company specializes in products for the environmental industry including ceramic membranes for liquid filtration and diesel particulate filters to control soot from diesel engines.LiqTech’s recent 3Q report included record quarterly revenue and net income. Revenue for 3Q19 was $9.7 million, representing a third consecutive quarter of record revenue. This figure is up from $9.3 million in the previous quarter and represents a 189% increase from 3Q18. Net income came in at $656,000, improving dramatically from a net loss of $922,000 in last year’s third quarter, and a big step up from $147,000 in 2Q.The fourth quarter, though, has seen LiqTech experience mechanical issues in two of the company’s four new furnaces on order. Nevertheless, Lake Street analyst Robert Brown expects LiqTech to overcome the issues. The first furnace is set for installation before the end of the year and should provide the company with an additional “$15M-$16M in quarterly revenue capacity.” With the IMO (international maritime organization) sulphur limit deadline of January 1, 2020 quickly approaching, the analyst notes “LiqTech's demand trends remain strong.”Therefore, Brown kept a Buy rating on LiqTech and a price target of $10.00, suggesting upside potential of a grand 89%. (To watch Brown’s track record, click here)According to Brown, then, LiqTech won’t be a micro-cap for much longer, but what do his colleagues think? Only 2 other analysts have kept tabs on the Scandinavian filtration wiz, but both deem LiqTech a Buy, therefore handing it a Strong Buy consensus rating. An average price target of $9.33 implies gains of 79% could be in the cards over the next year. (See LiqTech price targets and analyst ratings on TipRanks)

LiqTech International, Inc. (NASDAQ: LIQT) ("LiqTech"), a clean technology company that manufactures and markets highly specialized filtration technologies, announced today fourth quarter and record fiscal year 2019 financial results for the periods ended December 31, 2019.

Shares of LiqTech International (NASDAQ:LIQT) remained unaffected at $3.97 in pre-market trading after the company reported Q4 results.Quarterly Results Earnings per share decreased 100.00% over the past year to ($0.04), which missed the estimate of ($0.02).Revenue of $6,200,000 up by 114.16% year over year, which beat the estimate of $5,900,000.Outlook LiqTech International hasn't issued any earnings guidance for the time being.Q1 revenue expected to be between $12,000,000 and $12,000,000.Details Of The Call Date: Mar 26, 2020View more earnings on LIQTTime: 02:00 PM ETWebcast URL: https://www.liqtech.com/investor-relations/events-presentations/Technicals Company's 52-week high was at $10.6952-week low: $1.82Price action over last quarter: down 17.12%Company Profile LiqTech International Inc is a United States of America company. It is clean technology company which provides technology for gas and liquid purification by manufacturing ceramic silicon carbide filters. The company is engaged in three businesses that are diesel particulate filters (DPF) for the control of soot from diesel engines, turnkey ceramic membranes systems, and complete water treatment plants. The company's product portfolio consists of ceramic silicon membranes for liquid filtration, diesel particulate filters, and kiln furniture. Geographically, the company offers its services to the United States of America and Denmark.See more from Benzinga * Recap: Titan Machinery Q4 Earnings * Movado Group: Q4 Earnings Insights * Recap: Viomi Technology Co Q4 Earnings(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

LiqTech International, Inc. (NASDAQ: LIQT) ("LiqTech"), a clean technology company that manufactures and markets highly specialized filtration technologies, will host an investor day on Tuesday, January 21, 2020 commencing at 2:00pm CET local time (8:00am EST in New York), at the Company's facility in Ballerup, Denmark.

In this article we will take a look at whether hedge funds think LiqTech International Inc (NYSE:LIQT) is a good investment right now. We check hedge fund and billionaire investor sentiment before delving into hours of research. Hedge funds spend millions of dollars on Ivy League graduates, unconventional data sources, expert networks, and get tips […]

LiqTech International, Inc. (NASDAQ: LIQT) ("LiqTech"), a clean technology company that manufactures and markets highly specialized filtration technologies, announced today first quarter 2020 financial results for the period ended March 31, 2020.

BALLERUP, Denmark , Nov. 14, 2019 /PRNewswire/ -- LiqTech International, Inc. (NASDAQ: LIQT) ("LiqTech") ,   a clean technology company that manufactures and markets highly specialized filtration ...

Shares of LiqTech International (NASDAQ:LIQT) rallied 14% after the company reported Q1 results.Quarterly Results Earnings per share rose 0.00% over the past year to $0.02, which beat the estimate of $0.01.Revenue of $10,282,000 rose by 38.55% year over year, which beat the estimate of $9,940,000.Looking Ahead Earnings guidance hasn't been issued by the company for now.Revenue guidance hasn't been issued by the company for now.How To Listen To The Conference Call Date: May 11, 2020View more earnings on LIQTTime: 07:05 PM ETWebcast URL: https://www.liqtech.com/investor-relations/events-presentations/Technicals 52-week high: $10.6952-week low: $2.95Price action over last quarter: Up 20.90%Company Overview LiqTech International Inc is a clean technology company which provides technology for gas and liquid purification by manufacturing ceramic silicon carbide filters. The company is engaged in three businesses that are diesel particulate filters (DPF) for the control of soot from diesel engines, turnkey ceramic membranes systems, and complete water treatment plants. The company's product portfolio consists of ceramic silicon membranes for liquid filtration, diesel particulate filters, and kiln furniture. Geographically, the company offers its services to the United States of America and Denmark.See more from Benzinga * Recap: LiqTech International Q4 Earnings(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

LiqTech International, Inc. (NASDAQ: LIQT) ("LiqTech"), a clean technology company that manufactures and markets highly specialized filtration technologies, today announced the successful installation of a brand new customized furnace for use in the manufacture of the Company's proprietary silicon carbide membrane filters. The new furnace has throughputs that are more than 3x the Company's existing furnaces due to size and efficiency.

LiqTech International, Inc. (NASDAQ: LIQT) ("LiqTech"), a clean technology company that manufactures and markets highly specialized filtration technologies, today announced preliminary fiscal year 2019 financial results and provided an outlook for the first quarter of 2020.

BALLERUP, Denmark , Nov. 13, 2019 /PRNewswire/ --  LiqTech International, Inc. (NASDAQ: LIQT)  ("LiqTech"),  a clean technology company that manufactures and markets highly specialized filtration ...